NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
16/05/2021
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
LIPIVIEW
ST13
US500000077384342Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Fundamento do pedido
Primeiro uso
Primeiro uso no comércio
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Marci A. Blazer Johnson & Johnson
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Computer hardware and software, and parts and accessories therefor, for use with apparatus for analyzing, diagnosing, treating, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction
Classe 10
Medical apparatuses and devices, and parts and accessories therefor, used for analyzing [, diagnosing, treating, ] and monitoring eye disease, namely, dry eye and meibomian gland dysfunction;[ Medical device, and parts and accessories therefor, for expressing obstructions or occlusions from meibomian glands; Medical heater used primarily for medical purposes, namely, for applying heat to a patient's eye and related eye structure for treating eye diseases, namely, dry eye and meibomian gland dysfunction; Medical devices, namely, medical contact lens used primarily for medical purposes containing an electrical heating element for applying heat to meibomian glands when installed on a patient's eye for treating dry eye and meibomian gland dysfunction; ] Optical and photographic apparatus and instruments, and parts and accessories therefor, namely, interferometers and cameras, for analyzing, diagnosing, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction; medical imaging apparatuses and devices comprising optical lens, camera, lamp, LED, spectrometer, used for analyzing, diagnosing, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction [ ; electronic medical temperature controller, and parts and accessories therefor, used primarily for temperature controller purposes, namely, for delivering and controlling heat to meibomian glands for use in treating eye disease, namely, dry eye and meibomian gland dysfunction; electronic medical pressure controller, and parts and accessories therefor, used primarily for controlling pressure, namely, for applying and controlling pressure to the meibomian glands for use in treating eye disease, namely, dry eye and meibomian gland dysfunction; electronic medical fluid transfer controller, and parts and accessories therefor, used primarily for controlling and transferring heated fluid to the eye for use in treating eye disease, namely, dry eye and meibomian gland dysfunction ]
Classe 16
[ Printed instructional, educational and teaching materials in the field of eye disease, namely, dry eye and meibomian gland dysfunction; Printed instructional, educational and teaching materials for analysis, diagnosis, treatment, and monitoring of eye disease, namely, dry eye and meibomian gland dysfunction ]
Classe 41
[ Education services, namely, classes, conferences, seminars, workshops, in the field of eye disease, namely, dry eye and meibomian gland dysfunction; Education services, namely, providing seminars, tutorials, workshops for analyzing, diagnosing, treating, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction; Training services in the field of eye disease, namely, dry eye and meibomian gland dysfunction; Training services, namely, providing seminars, tutorials, workshops for analyzing, diagnosing, treating, and monitoring eye disease, namely, dry eye and meibomian gland dysfunction ]
Classe 44
[ Medical services, namely, providing medical analysis, diagnosis, treatment, and monitoring of eye diseases and conditions; Medical services, namely, providing medical analysis, diagnosis, treatment, and monitoring of dry eye and meibomian gland dysfunction; ] Providing medical information related to eye disease, namely, dry eye and meibomian gland dysfunction, for educational purposes
Histórico de despachos e eventos da marca no USPTO.
59 publicações encontradas
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
16/05/2021
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
16/05/2021
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
16/05/2021
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
16/05/2021
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
16/05/2021
TEAS SECTION 8 & 9 RECEIVED
05/02/2021
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/02/2020
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/06/2018
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/06/2018
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/04/2018
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/04/2018
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
16/06/2016
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
16/06/2016
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
16/06/2016
TEAS SECTION 8 & 15 RECEIVED
08/04/2016
REGISTERED-PRINCIPAL REGISTER
08/02/2011
NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
06/01/2011
LAW OFFICE REGISTRATION REVIEW COMPLETED
05/01/2011
ASSIGNED TO LIE
04/01/2011
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
15/12/2010
STATEMENT OF USE PROCESSING COMPLETE
07/12/2010
USE AMENDMENT FILED
02/12/2010
TEAS STATEMENT OF USE RECEIVED
02/12/2010
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
08/06/2010
SOU EXTENSION 3 GRANTED
07/06/2010
SOU EXTENSION 3 FILED
02/06/2010
SOU TEAS EXTENSION RECEIVED
02/06/2010
SOU EXTENSION 2 GRANTED
15/01/2010
CASE ASSIGNED TO INTENT TO USE PARALEGAL
14/01/2010
SOU EXTENSION 2 FILED
24/11/2009
SOU TEAS EXTENSION RECEIVED
24/11/2009
ASSIGNED TO EXAMINER
15/05/2009
SOU EXTENSION 1 GRANTED
06/05/2009
SOU EXTENSION 1 FILED
06/05/2009
SOU TEAS EXTENSION RECEIVED
06/05/2009
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
14/01/2009
NOA MAILED - SOU REQUIRED FROM APPLICANT
02/12/2008
PUBLISHED FOR OPPOSITION
09/09/2008
NOTICE OF PUBLICATION
20/08/2008
EXAMINERS AMENDMENT MAILED
08/08/2008
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/08/2008
APPROVED FOR PUB - PRINCIPAL REGISTER
07/08/2008
EXAMINER'S AMENDMENT ENTERED
07/08/2008
EXAMINERS AMENDMENT -WRITTEN
07/08/2008
PREVIOUS ALLOWANCE COUNT WITHDRAWN
04/08/2008
WITHDRAWN FROM PUB - OG REVIEW QUERY
01/08/2008
EXAMINERS AMENDMENT MAILED
21/07/2008
LAW OFFICE PUBLICATION REVIEW COMPLETED
18/07/2008
ASSIGNED TO LIE
18/07/2008
APPROVED FOR PUB - PRINCIPAL REGISTER
18/07/2008
EXAMINER'S AMENDMENT ENTERED
18/07/2008
EXAMINERS AMENDMENT -WRITTEN
18/07/2008
TEAS/EMAIL CORRESPONDENCE ENTERED
01/07/2008
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/07/2008
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/07/2008
NON-FINAL ACTION MAILED
12/05/2008
NON-FINAL ACTION WRITTEN
09/05/2008
ASSIGNED TO EXAMINER
08/05/2008
NEW APPLICATION ENTERED
04/02/2008
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.